Isabel Centeno (@isabelcentenos) 's Twitter Profile
Isabel Centeno

@isabelcentenos

Licensed Psychologist | PsychoOncologist | Elisabeth Kübler Faculty member | Cancer Advocate | CoAuthor Research in Creative Arts Therapies | Travesias De Tinta

ID: 923381419916910593

linkhttp://www.isabelcenteno.net calendar_today26-10-2017 02:51:00

799 Tweet

948 Takipçi

5,5K Takip Edilen

Dr. Linda E. Carlson 🇨🇦 🇨🇦 (@linda_e_carlson) 's Twitter Profile Photo

I am hiring for the newly funded Canadian Network of #Psychedelic-Assisted #Cancer Therapy. Looking for a postdoc and a Research Manager. Details on the UCalgary careers site: careers.ucalgary.ca/jobs/15873976-… CAPO Society for Integrative Oncology IMConsortium

IPOS (@ipospsychooncol) 's Twitter Profile Photo

📷 Today is the first-ever World Psycho-Oncology Day (WPOD)! On this day- April 9, Jimmie Holland’s birthday-we recognise the vital role of psycho-oncology in supporting individuals affected by cancer. #WorldPsychoOncologyDay #WPOD #PsychoOncology #CancerCare #MentalHealth

📷 Today is the first-ever World Psycho-Oncology Day (WPOD)!

On this day- April 9, Jimmie Holland’s birthday-we recognise the vital role of psycho-oncology in supporting individuals affected by cancer. 
#WorldPsychoOncologyDay #WPOD #PsychoOncology #CancerCare #MentalHealth
Isabel Centeno (@isabelcentenos) 's Twitter Profile Photo

Felices de tener este día para celebrar nuestro trabajo y la oportunidad de acompañarnos en esta profesión que nos llena de satisfacción Tania Estapé

IPOS (@ipospsychooncol) 's Twitter Profile Photo

ONE WEEK NOTICE! Live Webinar: Fear of Cancer Recurrence Special Interest Group (FORwards) presents Meet the Expert 19 Jun 2025, 9:00 AM - 10:00 AM EDT REGISTRATION – FREE for ALL - advance registration required. Register online by going to ipos-society.org/event-6207517

ONE WEEK NOTICE!
Live Webinar: Fear of Cancer Recurrence Special Interest Group (FORwards) presents Meet the Expert 

19 Jun 2025, 9:00 AM - 10:00 AM EDT

REGISTRATION – FREE for ALL - advance registration required.

Register online by going to ipos-society.org/event-6207517
Isabel Centeno (@isabelcentenos) 's Twitter Profile Photo

Gracias por invitarme a tu podcast: Crecer sin drama Muy contentas hablando sobre hacernos mayores conviviendo con un diagnóstico de cáncer. La importancia de la #psicooncología en la #oncogeriatría Disponible en Youtube

Gracias por invitarme a tu podcast: Crecer sin drama
Muy contentas hablando sobre hacernos mayores conviviendo con un diagnóstico de cáncer. La importancia de la #psicooncología en la #oncogeriatría 

Disponible en Youtube
Isabel Centeno (@isabelcentenos) 's Twitter Profile Photo

Ep 67: ¿CÓMO ACOMPAÑAR EN UN DIAGNÓSTICO DE CÁNCER? Isabel Centeno youtu.be/IOs8CmrPrTQ?si… vía YouTube #psicooncología #oncogeriatría

IPOS (@ipospsychooncol) 's Twitter Profile Photo

Special Message from the Journal of Psychosocial Oncology Research and Practice (JPORP) Advisory Board member, Melba D’Souza - the official Publication of IPOS youtube.com/watch?v=g1iT51… Learn more about JPORP by going to journals.lww.com/jporp/pages/de…

Special Message from the Journal of Psychosocial Oncology Research and Practice (JPORP) Advisory Board member, Melba D’Souza - the official Publication of IPOS youtube.com/watch?v=g1iT51…

Learn more about JPORP by going to journals.lww.com/jporp/pages/de…
Isabel Centeno (@isabelcentenos) 's Twitter Profile Photo

Happy to share our recent paper Christine Maheu Systematic Review of Fear of Cancer Recurrence Patient-Reported Outcome Measures: Evaluating Methodological Quality and Measurement Properties Using the COSMIN Checklist mdpi.com/3475456 #mdpihealthcare Healthcare MDPI

Valentina Gambardella (@valegambardella) 's Twitter Profile Photo

👏 Great job by Dr. Noelia Tarazona presenting the highlights on lower GI tumors at #ESMO25, from 💊 advances in CRC treatment to 🧬 novel biomarkers and 📊 trial results.

👏 Great job by Dr. <a href="/TarazonaNoelia/">Noelia Tarazona</a> presenting the highlights on lower GI tumors at #ESMO25, from 💊 advances in CRC treatment to 🧬 novel biomarkers and 📊 trial results.